Goodwin Names 29 New Partners

Global law firm Goodwin announced today that 29 lawyers have been elected to the firm’s partnership, effective immediately.

“Through their leadership and commitment to our clients, culture, and values, these exceptional lawyers have woven themselves into the fabric of our firm,” said Rob Insolia, Goodwin’s Chairman. “We are thrilled to welcome them to the partnership and look forward to their continuing contributions to our clients’ success at the intersection of capital and innovation.” 

The newly elected partners include:

	Alexander Philipp Apostolopoulos (Tax, New York) advises a wide range of clients on federal income taxation matters, with an emphasis on corporate and partnership transactions, initial public offerings, and real estate transactions.
	Alese L. Bagdol (Private Equity, Washington, D.C.) focuses on an array of private equity transactions with a particular focus on complex U.S. and cross-border growth equity investments, venture capital financings, mergers and acquisitions, leveraged buyouts, and direct secondary and private company liquidity programs.
	Katherine J. Baudistel (Private Equity, Santa Monica) counsels clients on wide array of corporate transactions, including mergers and acquisitions, leveraged buyouts, carve-outs, growth equity investments, and corporate governance.
	John G. Casnocha (Technology & Life Sciences, San Francisco) advises founders, emerging growth companies, and venture capital funds on corporate and transactional matters, including formations, venture capital financings, public offerings, and mergers and acquisitions.
	Benjamin Garçon (Private Equity, Paris) advises domestic and European private equity funds in their investment in French companies, with a particular focus on leveraged buyout transactions. He also advises startups and small- and medium-sized enterprises at various stages from incubation and equity financing rounds to external growth transactions and exits.
	Martin C. Gomez (Technology & Life Sciences, Boston) counsels technology and life sciences companies and their investors in corporate and intellectual property matters, including new company formation, IP protection, fundraising, strategic transactions, and exits.
	Sean P. Gruver (Real Estate Industry, New York) represents sponsors in the formation of private real estate debt and equity funds, and real estate investment managers, fund sponsors, and REITs in the formation of joint ventures and other private investment vehicles.
	Lauren Troxclair Lebioda (Real Estate Industry, Washington, D.C.) focuses on advising sponsors in establishing and managing private investment vehicles primarily focused on investing in the real estate and infrastructure sectors.
	Audrey S. Leigh (Real Estate Industry, New York) represents a diverse range of public and private companies, including investment banks and publicly traded REITs, in transactions such as IPOs, follow-on offerings, and private offerings of equity and debt securities.
	Natalie T. Martirossian (Technology & Life Sciences, Los Angeles) advises clients on pre-incorporation planning, general corporate matters, venture capital financings, mergers and acquisitions, public offerings, corporate governance, and SEC compliance.
	Lisa A.H. McChesney (Trusts & Estates, Boston) specializes in estate planning for high net worth individuals and families, estate administration, the formation and operation of nonprofit organizations, and issues related to charitable giving.
	Andrew Ong (IP Litigation, Silicon Valley) focuses on complex intellectual property matters, including patent and trade-secret matters, and litigates in federal courts and proceedings before the U.S. Patent and Trademark Office.
	Monica Patel (ERISA, Silicon Valley) advises both public and private companies with respect to the employee benefit and compensation aspects of mergers and acquisitions, initial public offerings, and other corporate transactions.
	Stephanie Richards (Technology & Life Sciences, Boston) advises life sciences companies and investors on general corporate representation, venture capital financings, mergers and acquisitions, public offerings, and SEC compliance.
	Matthew L. Riffee (Financial Industry, Washington, D.C.) focuses on ERISA and consumer financial services litigation, class actions, and representing banks and financial institutions in government investigations and enforcement actions.
	Paul R. Rosie (Technology & Life Sciences, Boston) specializes in general corporate representation, venture capital financings, mergers and acquisitions, public offerings, and SEC compliance.
	Darin See (Technology & Life Sciences, San Francisco) counsels emerging growth companies, venture capital firms, and private equity investment funds in transactions spanning the entire corporate life cycle.
	Levi Swank (Financial Industry, Washington, D.C.) represents banks and fintech companies in complex litigation and government enforcement matters related to compliance with federal and state consumer finance laws.
	Olivia D. Uitto (Technology & Life Sciences, Boston) counsels life sciences clients on worldwide patent prosecution, market exclusivities, patentability, and freedom to operate.
	Alexander J. Varond (Technology & Life Sciences, Washington, D.C.) represents life sciences clients on FDA regulatory matters, including medical device and drug development, Hatch-Waxman patent and exclusivity issues, and regulatory strategy.
	Isaac Vinyarsh (Private Equity, New York) advises private equity sponsors, venture capital funds, their portfolio companies, and corporate clients on a range of complex merger and acquisition transactions, growth equity investments, and general corporate matters.